News AVITA Medical, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
9.61 ^USD	+3.33%		+18.64%	-29.96%

May. 31	Avita Medical's Recell Go Obtains Approval from US FDA	MT
May. 30	Sector Update: Health Care Stocks Higher in Afternoon Trading	MT

Avita Medical's Recell Go Obtains Approval from US FDA	May. 30	MT
Sector Update: Health Care Stocks Higher in Afternoon Trading	May. 30	MT
Avita Medical Shares Rise After FDA Nod For Recell Go System	May. 30	MT
Sector Update: Health Care	May. 30	MT
Avita Medical Receives FDA Premarket Approval Supplement for Recell Go System	May. 30	MT
AVITA Medical Announces FDA Approval of RECELL GO	May. 30	AQ
AVITA Medical, Inc. Announces FDA Approval of RECELL GO	May. 30	CI
Transcript : AVITA Medical, Inc. - Special Call	May. 21
AVITA Medical to Host Investor Webinar Briefing	May. 16	AQ
Cantor Fitzgerald Trims Price Target on Avita Medical to $21 From $22, Maintains Overweight Rating	May. 14	MT
Piper Sandler Downgrades Avita Medical to Neutral From Overweight, Price Target is $9	May. 14	MT
Avita Medical Widens Q1 Loss as Sales, Marketing Expense Jumps; Shares Up 10%	May. 13	MT
Transcript : AVITA Medical, Inc., Q1 2024 Earnings Call, May 13, 2024	May. 13
AVITA Medical Reports First Quarter Financial Results	May. 13	AQ
AVITA Medical, Inc. Provides Earnings Guidance for the Second of 2024	May. 13	CI
AVITA Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 13	CI
Wilsons Downgrades Avita Medical to Market-Weight From Overweight; Price Target is AU$3.03	Apr. 17	MT
AVITA Medical to Announce First Quarter 2024 Financial Results	Apr. 15	AQ
BTIG Research Downgrades Avita Medical to Neutral From Buy	Apr. 11	MT
Avita Medical Lowers Q1 Revenue Guidance on Slower New Account Approvals	Apr. 10	MT

No results for this search